We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
M&T Bank
MTB
$36.2B
| $1.14M | 0.02% |
7,026
+5,310
| +309% | +$838K |
|
|
552
Agilent Technologies
A
$39.1B
| $1.13M | 0.02% |
19,070
-464,156
| -96% | -$26.4M |
|
553
Azenta
AZTA
$1.26B
| $1.13M | 0.02% |
52,026
-500
| -1% | -$12.7K |
|
554
Costamare
CMRE
$1.9B
| $1.12M | 0.02% |
153,409
-198,699
| -56% | -$1.39M |
|
555
Employers Holdings
EIG
$908M
| $1.11M | 0.02% |
26,350
-840
| -3% | -$33.8K |
|
556
ABM Industries
ABM
$2.8B
| $1.11M | 0.02% |
26,776
-440
| -2% | -$18.7K |
|
557
CRA International
CRAI
$1.1B
| $1.09M | 0.02% |
29,956
+10,050
| +50% | +$355K |
|
558
Moelis & Co
MC
$4.98B
| $1.07M | 0.02% |
27,622
-80,768
| -75% | -$3.01M |
|
559
Norwegian Cruise Line
NCLH
$8.89B
| $1.06M | 0.02% |
19,570
-1,470
| -7% | -$75.9K |
|
560
Standard Motor Products
SMP
$861M
| $1.06M | 0.02% |
+20,240
| New | +$1.01M |
|
|
FCB
561
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.05M | 0.02% |
22,030
-13,350
| -38% | -$632K |
|
|
HIFR
562
DELISTED
InfraREIT, Inc.
HIFR
| $1.05M | 0.02% |
54,773
+8,900
| +19% | +$169K |
|
|
XENT
563
DELISTED
Intersect ENT, Inc
XENT
| $1.02M | 0.02% |
36,512
-30,424
| -45% | -$689K |
|
564
Bristol-Myers Squibb
BMY
$127B
| $1.01M | 0.02% |
18,190
+4,490
| +33% | +$244K |
|
565
Pixelworks
PXLW
$38.8M
| $1.01M | 0.02% |
18,371
+6,489
| +55% | +$381K |
|
566
Andersons Inc
ANDE
$2.65B
| $1.01M | 0.02% |
29,480
-96,084
| -77% | -$3.43M |
|
567
ON Semiconductor
ON
$33.8B
| $987K | 0.02% |
70,330
-1,351,865
| -95% | -$20.3M |
|
|
HIVE
568
DELISTED
Aerohive Networks
HIVE
| $984K | 0.02% |
196,762
+70,000
| +55% | +$313K |
|
569
Workiva
WK
$2.94B
| $970K | 0.02% |
50,921
+10,280
| +25% | +$182K |
|
570
First Solar
FSLR
$21.8B
| $969K | 0.02% |
+24,310
| New | +$826K |
|
571
VeriSign
VRSN
$25.5B
| $954K | 0.02% |
+10,260
| New | +$927K |
|
|
NP
572
DELISTED
Neenah, Inc. Common Stock
NP
| $951K | 0.02% |
11,850
-2,420
| -17% | -$188K |
|
|
CADE
573
DELISTED
Cadence Bank
CADE
| $949K | 0.02% |
31,101
+8,670
| +39% | +$260K |
|
574
Teradata
TDC
$2.68B
| $945K | 0.02% |
32,040
+6,890
| +27% | +$202K |
|
|
TGH
575
DELISTED
Textainer Group Holdings limited
TGH
| $941K | 0.02% |
64,910
-8,800
| -12% | -$116K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.